表紙
市場調查報告書

間質幹細胞的全球市場

Mesenchymal Stem Cells (MSC)

出版商 Global Industry Analysts, Inc. 商品編碼 297189
出版日期 內容資訊 英文 185 Pages
商品交期: 最快1-2個工作天內
價格
間質幹細胞的全球市場 Mesenchymal Stem Cells (MSC)
出版日期: 2020年09月01日內容資訊: 英文 185 Pages
簡介

本報告提供間質幹細胞的全球市場分析。還有關於美國、加拿大、日本、歐洲、亞太地區及其他地區的各地區各種綜合分析、從2015年到2022年的各年估計與預測。加上含主要企業與利基企業的47家公司簡介,為您概述為以下內容。。

第1章 簡介·分析方法·產品定義

第2章 市場概要

  • 間質幹細胞 (MSC) 市場:急速成長過程
  • 現狀/未來分析
  • MSC治療的現狀與未來性
    • 選擇基於MSC的治療方法
  • 間質幹細胞的相關分析·臨床實驗
    • 完成的第三階段臨床實驗
  • MSCs正在探索幾種新的治療可能性
  • 「off-the-shelf」MSC的大規模商業化,成為現實
  • 軟體企業努力在繁榮中獲利

第3章 市場促進因素·趨勢·課題

  • 再生醫療的發展加速了對MSCs的需求
  • 人口的高齡化促進MSC療法的需求
    • 全球老年人口的統計資料:市場機會的指標
  • 慢性疾病患者增加,促進MSC的需求
    • 主要疾病的統計資料:市場機會的指標
  • 整形外科手術的數量增加:MSC的市場機會
  • 胚胎幹細胞研究相關的永遠爭議,成體幹細胞療法對生長軌蹟的影響
    • 成體幹細胞及胚胎幹細胞 - 比較
  • 間質幹細胞 vs 胚胎/誘導性多功能幹細胞
  • 間質幹細胞療法,不受胚胎幹細胞適用的倫理問題的影響
  • MSCs - '靶向藥物輸送'的潛在載體
  • 幹細胞相關的骨移植片:有望實現成長
  • 體內特性相關的漏洞,促進治療方法的進步
  • 擋住間質幹細胞市場的一大課題
  • 同種異體的間質幹細胞:免疫抑制/組織修復治療領域的市場機會
  • 給藥途徑左右間質幹細胞有效性

第4章 主要幹細胞變異體分析

  • 成體幹細胞
    • 低風險的投資
    • 成體幹細胞研究投入更多資金
    • 低通用性 - 成體幹細胞的主要阻礙因素
  • 造血幹細胞 - 享受持久的成功
    • 阻礙因素
  • 誘導性多功能幹細胞 (iPS細胞) - ESC的替代品
    • iPS的發現
    • 醫藥品開發 - IPS的主要應用領域
    • 再生醫療上iPS的使用
    • 確立iPS細胞庫
  • 難治性和先天性疾病治療
  • 胚胎幹細胞改變醫學
    • 倫理問題和技術性門檻轉變hESC研究
  • 缺乏安全性和有效性數據 - 一個關鍵問題

第5章 間質幹細胞 (MSC) 市場分析:各用途

  • 整形外科的間質幹細胞
    • 整形手術上基於間質幹細胞的模式
    • MSC供給到需要治療的區域
    • 骨關節炎治療上的間質幹細胞
    • 類風濕性關節炎治療上的間質幹細胞
  • 癌症治療上的間質幹細胞
  • 肝臟學上的間質幹細胞
  • 神經學上的間質幹細胞
  • 心臟病上的間質幹細胞
  • 放射治療上的間質幹細胞
  • 糖尿病治療上的間質幹細胞
  • 治療自體免疫疾病上的間質幹細胞
    • 放射治療上的間質幹細胞
  • 卵巢早衰 (POF) 治療上的間質幹細胞
  • 基因治療上的間質幹細胞
  • 肺部疾病治療上的間質幹細胞
  • 肝臟病治療上的間質幹細胞
  • 多發性硬化症 (MS) 治療上的間質幹細胞
  • 結腸修復上的間質幹細胞
  • 腎修復上的間質幹細胞

第6章 產品概要

  • 間質幹細胞(MSC)- 序
  • 歷史
  • 同類間質幹細胞是什麼?
  • 間質幹細胞的幾個的主要供給來源
    • 骨髓
    • 果凍,臍帶血
    • 脂肪組織
    • 滋養細胞組織
    • 羊水
    • 下頜第三磨牙牙齒發育的研究
  • 間質幹細胞的治療機制
  • 間質幹細胞的重要功能
    • 形態學
    • 識別/檢測
    • 分化能力
    • 免疫調節作用
    • 培養
  • 臨床用途
  • 生產臨床等級的MSC
  • 間質幹細胞 (MSC)的缺點

第7章 競爭環境

  • 主要企業分析
  • 產品銷售趨勢
  • 最近的產業活動

第8章 全球市場的未來展望

第9章 世界各地的市場未來展望

  • 美國
  • 加拿大
  • 日本
  • 歐洲
  • 亞太地區
  • 其他的國家 (RoW)

第10章 企業簡介

  • 主要企業的概要

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP-7815

Global Mesenchymal Stem Cells (MSC) Market to Reach $229 Million by 2027

Amid the COVID-19 crisis, the global market for Mesenchymal Stem Cells (MSC) estimated at US$172.9 Million in the year 2020, is projected to reach a revised size of US$229 Million by 2027, growing at a CAGR of 4.1% over the analysis period 2020-2027. Human MSC, one of the segments analyzed in the report, is projected to record a 4.6% CAGR and reach US$94.8 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Mouse MSC segment is readjusted to a revised 4% CAGR for the next 7-year period.

The U.S. Market is Estimated at $50.9 Million, While China is Forecast to Grow at 3.9% CAGR

The Mesenchymal Stem Cells (MSC) market in the U.S. is estimated at US$50.9 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$40.6 Million by the year 2027 trailing a CAGR of 3.9% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.8% and 3.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.

Rat MSC Segment to Record 3.8% CAGR

In the global Rat MSC segment, USA, Canada, Japan, China and Europe will drive the 3.9% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$27.7 Million in the year 2020 will reach a projected size of US$36.2 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$25.5 Million by the year 2027.We bring years of research experience to this 19th edition of our report. The 185-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

  • Cell Applications Inc.
  • Celprogen Inc.
  • Cyagen US Inc.
  • Genlantis Inc.
  • Lonza Group
  • Mesoblast Limited
  • MilliporeSigma
  • Neuromics
  • Orthofix International N.V.
  • PromoCell GmbH
  • R&D Systems Inc.
  • ScienCell Research Laboratories
  • Stemcell Technologies Inc.
  • Stemedica Cell Technologies Inc.
  • Thermo Fischer Scientific Inc.

TABLE OF CONTENTS

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Mesenchymal Stem Cells Market on a Rapid Growth Path
    • Recent Market Activity
    • Current and Future Analysis
    • The Present and Future of MSC Therapies
    • Select MSC-based Therapeutics
    • Mesenchymal Stem Cell Research
    • Completed Phase III Studies with MSCs
    • MSCs are Being Explored for Several New Treatment Possibilities
    • Widespread Commercialization of 'Off-the-Shelf' MSCs to Become a Reality
    • Software Companies Endeavour to Cash in on the Boom
    • Global Competitor Market Shares
    • Mesenchymal Stem Cells (MSC) Competitor Market Share Scenario Worldwide (in %): 2018 &
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
    • Cell Applications, Inc. (USA)
    • Celprogen, Inc. (USA)
    • Cyagen US Inc. (USA)
    • Genlantis, Inc. (USA)
    • Lonza Group (Switzerland)
    • Mesoblast Limited (Australia)
    • MilliporeSigma (USA)
    • Neuromics (USA)
    • Orthofix International N.V. (Italy)
    • PromoCell GmbH (Germany)
    • R&D Systems, Inc. (USA)
    • ScienCell Research Laboratories (USA)
    • Stemcell Technologies Inc. (Canada)
    • Stemedica Cell Technologies, Inc. (USA)
    • Thermo Fischer Scientific, Inc. (USA)
    • Vitro Biopharma (USA)
  • 3. MARKET TRENDS & DRIVERS
    • Development of Regenerative Medicine Accelerates Demand for MSCs
    • Ageing Demographics to Drive Demand for Mesenchymal Stem Cell Therapies
    • Global Aging Population Statistics - Opportunity Indicators
    • Growing Prevalence of Chronic Diseases Propels Demand for Mesenchymal Stem Cells
    • Key Disease Statistics - Opportunity Indicators
    • Growing Volume of Orthopedic Procedures: An Opportunity for the MSC Market
    • Adult Stem Cell Therapies on Growth Trajectory, as Controversies Continue to Haunt Embryonic Stem Cell Research
    • Adult Stem Cells and Embryonic Stem Cells - A Comparison
    • MSCs Versus Embryonic or Induced Pluripotent Stem Cells
    • MSC Therapies - Immune to Ethical Issues Applicable to Embryonic Stem Cells
    • MSCs - A Potential Vehicle for 'Targeted Drug Delivery'
    • Stem Cell Based Bone Grafts: Promising Growth Ahead
    • Loopholes Associated with In Vivo Properties Constrain Therapeutic Advancements
    • Major Challenges Confronting Mesenchymal Stem Cell Market
    • Allogeneic MSCs - Offering Promise in Immunosuppressive and Tissue Repair Therapy
    • Administration Route Determines the Effectiveness of MSCs
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: Mesenchymal Stem Cells (MSC) Global Market Estimates and Forecasts in US$ Thousand by Region/Country: 2020
    • TABLE 2: Mesenchymal Stem Cells (MSC) Global Retrospective Market Scenario in US$ Thousand by Region/Country: 2012
    • TABLE 3: Mesenchymal Stem Cells (MSC) Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS
    • TABLE 4: Human MSC (Type) World Market by Region/Country in US$ Thousand: 2020 to
    • TABLE 5: Human MSC (Type) Historic Market Analysis by Region/Country in US$ Thousand: 2012 to
    • TABLE 6: Human MSC (Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS
    • TABLE 7: Mouse MSC (Type) Potential Growth Markets Worldwide in US$ Thousand: 2020 to
    • TABLE 8: Mouse MSC (Type) Historic Market Perspective by Region/Country in US$ Thousand: 2012 to
    • TABLE 9: Mouse MSC (Type) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS
    • TABLE 10: Rat MSC (Type) Geographic Market Spread Worldwide in US$ Thousand: 2020 to
    • TABLE 11: Rat MSC (Type) Region Wise Breakdown of Global Historic Demand in US$ Thousand: 2012 to
    • TABLE 12: Rat MSC (Type) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS
    • TABLE 13: Other Types (Type) World Market Estimates and Forecasts by Region/Country in US$ Thousand: 2020 to
    • TABLE 14: Other Types (Type) Market Historic Review by Region/Country in US$ Thousand: 2012 to
    • TABLE 15: Other Types (Type) Market Share Breakdown by Region/Country: 2012 VS 2020 VS
    • TABLE 16: Research Institutes (Application) Worldwide Latent Demand Forecasts in US$ Thousand by Region/Country: 2020
    • TABLE 17: Research Institutes (Application) Global Historic Analysis in US$ Thousand by Region/Country: 2012
    • TABLE 18: Research Institutes (Application) Distribution of Global Sales by Region/Country: 2012 VS 2020 VS
    • TABLE 19: Hospitals (Application) Sales Estimates and Forecasts in US$ Thousand by Region/Country for the Years 2020 through
    • TABLE 20: Hospitals (Application) Analysis of Historic Sales in US$ Thousand by Region/Country for the Years 2012 to
    • TABLE 21: Hospitals (Application) Global Market Share Distribution by Region/Country for 2012, 2020, and
    • TABLE 22: Other Applications (Application) Global Opportunity Assessment in US$ Thousand by Region/Country: 2020
    • TABLE 23: Other Applications (Application) Historic Sales Analysis in US$ Thousand by Region/Country: 2012
    • TABLE 24: Other Applications (Application) Percentage Share Breakdown of Global Sales by Region/Country: 2012 VS 2020 VS

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Mesenchymal Stem Cells (MSC) Market Share (in %) by Company: 2018 &
    • Market Analytics
    • TABLE 25: United States Mesenchymal Stem Cells (MSC) Market Estimates and Projections in US$ Thousand by Type: 2020 to
    • TABLE 26: Mesenchymal Stem Cells (MSC) Market in the United States by Type: A Historic Review in US$ Thousand for 2012
    • TABLE 27: United States Mesenchymal Stem Cells (MSC) Market Share Breakdown by Type: 2012 VS 2020 VS
    • TABLE 28: United States Mesenchymal Stem Cells (MSC) Latent Demand Forecasts in US$ Thousand by Application: 2020 to
    • TABLE 29: Mesenchymal Stem Cells (MSC) Historic Demand Patterns in the United States by Application in US$ Thousand for 2012
    • TABLE 30: Mesenchymal Stem Cells (MSC) Market Share Breakdown in the United States by Application: 2012 VS 2020 VS
  • CANADA
    • TABLE 31: Canadian Mesenchymal Stem Cells (MSC) Market Estimates and Forecasts in US$ Thousand by Type: 2020 to
    • TABLE 32: Canadian Mesenchymal Stem Cells (MSC) Historic Market Review by Type in US$ Thousand: 2012
    • TABLE 33: Mesenchymal Stem Cells (MSC) Market in Canada: Percentage Share Breakdown of Sales by Type for 2012, 2020, and
    • TABLE 34: Canadian Mesenchymal Stem Cells (MSC) Market Quantitative Demand Analysis in US$ Thousand by Application: 2020 to
    • TABLE 35: Mesenchymal Stem Cells (MSC) Market in Canada: Summarization of Historic Demand Patterns in US$ Thousand by Application for 2012
    • TABLE 36: Canadian Mesenchymal Stem Cells (MSC) Market Share Analysis by Application: 2012 VS 2020 VS
  • JAPAN
    • TABLE 37: Japanese Market for Mesenchymal Stem Cells (MSC): Annual Sales Estimates and Projections in US$ Thousand by Type for the Period 2020
    • TABLE 38: Mesenchymal Stem Cells (MSC) Market in Japan: Historic Sales Analysis in US$ Thousand by Type for the Period 2012
    • TABLE 39: Japanese Mesenchymal Stem Cells (MSC) Market Share Analysis by Type: 2012 VS 2020 VS
    • TABLE 40: Japanese Demand Estimates and Forecasts for Mesenchymal Stem Cells (MSC) in US$ Thousand by Application: 2020 to
    • TABLE 41: Japanese Mesenchymal Stem Cells (MSC) Market in US$ Thousand by Application: 2012
    • TABLE 42: Mesenchymal Stem Cells (MSC) Market Share Shift in Japan by Application: 2012 VS 2020 VS
  • CHINA
    • TABLE 43: Chinese Mesenchymal Stem Cells (MSC) Market Growth Prospects in US$ Thousand by Type for the Period 2020
    • TABLE 44: Mesenchymal Stem Cells (MSC) Historic Market Analysis in China in US$ Thousand by Type: 2012
    • TABLE 45: Chinese Mesenchymal Stem Cells (MSC) Market by Type: Percentage Breakdown of Sales for 2012, 2020, and
    • TABLE 46: Chinese Demand for Mesenchymal Stem Cells (MSC) in US$ Thousand by Application: 2020 to
    • TABLE 47: Mesenchymal Stem Cells (MSC) Market Review in China in US$ Thousand by Application: 2012
    • TABLE 48: Chinese Mesenchymal Stem Cells (MSC) Market Share Breakdown by Application: 2012 VS 2020 VS
  • EUROPE
    • Market Facts & Figures
    • European Mesenchymal Stem Cells (MSC) Market: Competitor Market Share Scenario (in %) for 2018 &
    • Market Analytics
    • TABLE 49: European Mesenchymal Stem Cells (MSC) Market Demand Scenario in US$ Thousand by Region/Country: 2020
    • TABLE 50: Mesenchymal Stem Cells (MSC) Market in Europe: A Historic Market Perspective in US$ Thousand by Region/Country for the Period 2012
    • TABLE 51: European Mesenchymal Stem Cells (MSC) Market Share Shift by Region/Country: 2012 VS 2020 VS
    • TABLE 52: European Mesenchymal Stem Cells (MSC) Market Estimates and Forecasts in US$ Thousand by Type: 2020
    • TABLE 53: Mesenchymal Stem Cells (MSC) Market in Europe in US$ Thousand by Type: A Historic Review for the Period 2012
    • TABLE 54: European Mesenchymal Stem Cells (MSC) Market Share Breakdown by Type: 2012 VS 2020 VS
    • TABLE 55: European Mesenchymal Stem Cells (MSC) Addressable Market Opportunity in US$ Thousand by Application: 2020
    • TABLE 56: Mesenchymal Stem Cells (MSC) Market in Europe: Summarization of Historic Demand in US$ Thousand by Application for the Period 2012
    • TABLE 57: European Mesenchymal Stem Cells (MSC) Market Share Analysis by Application: 2012 VS 2020 VS
  • FRANCE
    • TABLE 58: Mesenchymal Stem Cells (MSC) Market in France by Type: Estimates and Projections in US$ Thousand for the Period 2020
    • TABLE 59: French Mesenchymal Stem Cells (MSC) Historic Market Scenario in US$ Thousand by Type: 2012
    • TABLE 60: French Mesenchymal Stem Cells (MSC) Market Share Analysis by Type: 2012 VS 2020 VS
    • TABLE 61: Mesenchymal Stem Cells (MSC) Quantitative Demand Analysis in France in US$ Thousand by Application: 2020
    • TABLE 62: French Mesenchymal Stem Cells (MSC) Historic Market Review in US$ Thousand by Application: 2012
    • TABLE 63: French Mesenchymal Stem Cells (MSC) Market Share Analysis: A 17-Year Perspective by Application for 2012, 2020, and
  • GERMANY
    • TABLE 64: Mesenchymal Stem Cells (MSC) Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Type for the Period 2020
    • TABLE 65: German Mesenchymal Stem Cells (MSC) Historic Market Analysis in US$ Thousand by Type: 2012
    • TABLE 66: German Mesenchymal Stem Cells (MSC) Market Share Breakdown by Type: 2012 VS 2020 VS
    • TABLE 67: Mesenchymal Stem Cells (MSC) Market in Germany: Annual Sales Estimates and Forecasts in US$ Thousand by Application for the Period 2020
    • TABLE 68: German Mesenchymal Stem Cells (MSC) Market in Retrospect in US$ Thousand by Application: 2012
    • TABLE 69: Mesenchymal Stem Cells (MSC) Market Share Distribution in Germany by Application: 2012 VS 2020 VS
  • ITALY
    • TABLE 70: Italian Mesenchymal Stem Cells (MSC) Market Growth Prospects in US$ Thousand by Type for the Period 2020
    • TABLE 71: Mesenchymal Stem Cells (MSC) Historic Market Analysis in Italy in US$ Thousand by Type: 2012
    • TABLE 72: Italian Mesenchymal Stem Cells (MSC) Market by Type: Percentage Breakdown of Sales for 2012, 2020, and
    • TABLE 73: Italian Demand for Mesenchymal Stem Cells (MSC) in US$ Thousand by Application: 2020 to
    • TABLE 74: Mesenchymal Stem Cells (MSC) Market Review in Italy in US$ Thousand by Application: 2012
    • TABLE 75: Italian Mesenchymal Stem Cells (MSC) Market Share Breakdown by Application: 2012 VS 2020 VS
  • UNITED KINGDOM
    • TABLE 76: United Kingdom Market for Mesenchymal Stem Cells (MSC): Annual Sales Estimates and Projections in US$ Thousand by Type for the Period 2020
    • TABLE 77: Mesenchymal Stem Cells (MSC) Market in the United Kingdom: Historic Sales Analysis in US$ Thousand by Type for the Period 2012
    • TABLE 78: United Kingdom Mesenchymal Stem Cells (MSC) Market Share Analysis by Type: 2012 VS 2020 VS
    • TABLE 79: United Kingdom Demand Estimates and Forecasts for Mesenchymal Stem Cells (MSC) in US$ Thousand by Application: 2020 to
    • TABLE 80: United Kingdom Mesenchymal Stem Cells (MSC) Market in US$ Thousand by Application: 2012
    • TABLE 81: Mesenchymal Stem Cells (MSC) Market Share Shift in the United Kingdom by Application: 2012 VS 2020 VS
  • REST OF EUROPE
    • TABLE 82: Rest of Europe Mesenchymal Stem Cells (MSC) Market Estimates and Forecasts in US$ Thousand by Type: 2020
    • TABLE 83: Mesenchymal Stem Cells (MSC) Market in Rest of Europe in US$ Thousand by Type: A Historic Review for the Period 2012
    • TABLE 84: Rest of Europe Mesenchymal Stem Cells (MSC) Market Share Breakdown by Type: 2012 VS 2020 VS
    • TABLE 85: Rest of Europe Mesenchymal Stem Cells (MSC) Addressable Market Opportunity in US$ Thousand by Application: 2020
    • TABLE 86: Mesenchymal Stem Cells (MSC) Market in Rest of Europe: Summarization of Historic Demand in US$ Thousand by Application for the Period 2012
    • TABLE 87: Rest of Europe Mesenchymal Stem Cells (MSC) Market Share Analysis by Application: 2012 VS 2020 VS
  • ASIA-PACIFIC
    • TABLE 88: Mesenchymal Stem Cells (MSC) Market in Asia-Pacific by Type: Estimates and Projections in US$ Thousand for the Period 2020
    • TABLE 89: Asia-Pacific Mesenchymal Stem Cells (MSC) Historic Market Scenario in US$ Thousand by Type: 2012
    • TABLE 90: Asia-Pacific Mesenchymal Stem Cells (MSC) Market Share Analysis by Type: 2012 VS 2020 VS
    • TABLE 91: Mesenchymal Stem Cells (MSC) Quantitative Demand Analysis in Asia-Pacific in US$ Thousand by Application: 2020
    • TABLE 92: Asia-Pacific Mesenchymal Stem Cells (MSC) Historic Market Review in US$ Thousand by Application: 2012
    • TABLE 93: Asia-Pacific Mesenchymal Stem Cells (MSC) Market Share Analysis: A 17-Year Perspectiveby Application for 2012, 2020, and
  • REST OF WORLD
    • TABLE 94: Rest of World Mesenchymal Stem Cells (MSC) Market Estimates and Forecasts in US$ Thousand by Type: 2020 to
    • TABLE 95: Rest of World Mesenchymal Stem Cells (MSC) Historic Market Review by Type in US$ Thousand: 2012
    • TABLE 96: Mesenchymal Stem Cells (MSC) Market in Rest of World: Percentage Share Breakdown of Sales by Type for 2012, 2020, and
    • TABLE 97: Rest of World Mesenchymal Stem Cells (MSC) Market Quantitative Demand Analysis in US$ Thousand by Application: 2020 to
    • TABLE 98: Mesenchymal Stem Cells (MSC) Market in Rest of World: Summarization of Historic Demand Patterns in US$ Thousand by Application for 2012
    • TABLE 99: Rest of World Mesenchymal Stem Cells (MSC) Market Share Analysis by Application: 2012 VS 2020 VS

IV. COMPETITION

  • Total Companies Profiled: 47